Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its surgical systems; progressive learning pathways to support the use of its technology; a complement of services to its customers, including support, installation, repair, and maintenance; and integrated digital capabilities providing unified and connected offerings, streamlining performance for hospitals with program-enhancing insights. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.

Intuitive Surgical, Inc.

Intuitive develops, manufactures, and markets robotic-assisted surgical systems, particularly the da Vinci Surgical System, for minimally invasive surgery.

Intuitive

Intuitive Fosun Hong Kong

Intuitive Israel

Intuitive Fosun

Intuitive (Nasdaq: ISRG), headquartered in Sunnyvale, Calif., is a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery. At Intuitive, we believe that minimally invasive care is life-enhancing care. Through ingenuity and intelligent technology, we expand the potential of physicians to heal without constraints.

Our three-webinar series, Expert Perspectives in Thoracic Oncology, continues with our second episode: Aligning Stakeholders with Data to Improve Patient Pathways.

In this conversation, Dr. Pepper and Moses Cone Thoracic Oncology Team will discuss the importance of engaging with a variety of multidisciplinary colleagues as you build your thoracic oncology program.

July 11th, 2000, isn’t where our story began, but it was a landmark day in our mission to transform surgery—the day that the first da Vinci Surgical System received FDA clearance. 
 
In the years since, surgeons around the world have used five generations of da Vinci systems to help millions of patients. Each generation was an evolution of technology on a journey of progress that never truly ends.
 
Transforming surgery for the benefit of patients, surgeons, and hospitals—that’s Intuitive.

Six years ago, when Intuitive’s Women in da Vinci Surgery Symposium began, there were just six female surgeons in the room. This year? Over 200 surgeons, pulmonologists, and hospital executives gathered in Atlanta, Georgia, to connect, learn, and grow together.

Explore key takeaways from this year’s symposium.

“The best way to grow our people is to grow our business,” says Anuj Mittal, CFO of Intuitive India. Over the past few years, our business has experienced incredible growth, but there's still a massive untapped opportunity in India. We’re looking for talented individuals ready to seize this moment.

At Intuitive India, we’re not just transforming healthcare; we’re building transformative careers. Our vision of enhancing minimally invasive care drives us to innovate, challenge ourselves, and lead in our industry.

Curious to learn more? We sat down with Anuj and fellow leaders Amit Garg and Keith Lavery to discuss the vast opportunities for new team members and the collaborative culture that fuels our growth. Discover insights about our new Global Capability Center and how we’re just scratching the surface of what’s possible.

Ready to be part of something bigger? Read the full story on our blog and see how you can make a real impact with us.
https://lnkd.in/e8RmZn_a
 
#WeAreIntuitive

When Dr. Laila Rashidi was asked how she communicates the benefits of robotic surgery to her patients and colleagues, she said, "Whenever I meet referring physicians or talk to my patients, I always have data to support why I'm doing what I'm doing."

In our new Surgeon Spotlight series, we'll be exploring the world of surgery through the eyes of some of the most skilled and knowledgable physicians in the world. Up first, the inimitable Dr. Laila Rashidi, medical director for colon and rectal surgery at MultiCare Health System.

“The marriage of Case Insights and the ability to review my operative videos—we’re finally at a point where I can put data to the words I’ve been trying to articulate with my fellows for a decade.”
-Mark Soliman, Medical Director of Colorectal Surgery for AdventHealth.

Explore how Case Insights enables surgeons to understand surgical performance like never before.

https://lnkd.in/eEinD5MG

Metric
Company Name	Intuitive Surgical, Inc.
Symbol	ISRG
MSH ID	COM:INTUITIVE
Market	STOCKS
Sector	Healthcare
Industry	Medical - Instruments & Supplies
Country	US
Stage
Employee Count	13.68K
Website	intuitive.com
LinkedIn	intuitivesurgical
Founders

Metric
Market Cap	157.75B
Enterprise Value
Monthly Web Traffic	118
Web Traffic Growth	-0.93
Valuation
Raised Capital

Metric
Revenue	7.12B
Revenue (LTM)
Revenue (NTM)
Gross Profit	4.73B
EBITDA	2.19B
Operating Income	1.77B
Net Income	1.80B
EPS	5.12
Diluted EPS	5.03
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin	0.67
Operating Profit Margin	0.26
EBITDA Margin	0.31
Net Profit Margin	0.29
Return on Equity	0.16
Return on Assets	0.13
Return on Capital Employed	0.13

NASDAQ:ISRG

Intuitive

Last Close

550.62

22/11 21:00

Market Cap

157.75B

Beta: 1.31

Volume Today

1.38M

Avg: 1.66M

PE Ratio

75.13

PFCF: 180.33

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio	75.13
P/B Ratio	10.15
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio	23.54
EV Multiple	77.89

Metric
Days Sales Outstanding	64.94
Days Payables Outstanding	28.76
Days Inventory Outstanding	208.21
Operating Cycle	261.70
Cash Conversion Cycle	232.91
Asset Turnover	0.46

Metric
Operating Cash Flow	1.81B
Free Cash Flow	749.60M
Cash Flow to Debt	16.72
Operating Cash Flow/Sales	0.25
Free Cash Flow Yield	0.01

Metric
Cash & Equivalents	2.75B
Accounts Receivable	-186.30M
Inventory	1.22B
Goodwill	348.70M
Debt to Capitalization	0.01
Debt to Assets
Current Ratio	4.76
Quick Ratio	4.41

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue	0.08
R&D to Revenue	0.14
SG&A to Revenue